全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2017 

miR-106b对鼻咽癌细胞凋亡的促进和对增殖的抑制作用
miR-106b induces the apoptosis and inhibits the proliferation of nasopharyngeal carcinoma cells

DOI: 10.7652/jdyxb201706013

Keywords: miR-106b,鼻咽癌,凋亡,增殖,RhoC
miR-106b
,nasopharyngeal carcinoma,apoptosis,proliferation,RhoC

Full-Text   Cite this paper   Add to My Lib

Abstract:

摘要:目的 探讨miR-106b对鼻咽癌细胞凋亡和增殖的影响。方法 应用miRNA芯片分析获得鼻咽癌组织和癌旁正常组织表达差异的miRNA,TaqMan miRNA检测试剂盒和实时荧光定量PCR分别检测miR-106和RhoC mRNA在鼻咽癌和癌旁组织中的表达,用miRnada预测miR-106b和靶基因的结合位点,采用双荧光素酶验证靶基因,Western blot检测miR-106b调控靶基因RhoC的表达水平。用Annexin V-PI和TUNEL检测miR-106b对鼻咽癌细胞凋亡的影响,用MTT检测miR-106b对鼻咽癌细胞增殖的影响。结果 miRNA芯片分析发现鼻咽癌组织中miR-106b的表达较癌旁正常组织低。RT-PCR结果显示miR-106b在鼻咽癌组织中表达减少(P<0.05),RhoC在鼻咽癌组织中表达增加(P<0.05),miR-106b和RhoC在鼻咽癌组织中表达呈负相关(r=?D0.5866,P<0.001)。荧光素酶报告基因实验结果显示miR-106b组荧光素酶活性低于空质粒组(P<0.05),Western blot结果显示miR-106b组鼻咽癌细胞中RhoC的表达较空质粒组降低(P<0.05)。Annexin V-PI和TUNEL结果显示,miR-106b组鼻咽癌细胞凋亡较空质粒组增加(P<0.05);MTT结果显示miR-106b组鼻咽癌细胞增殖能力较空质粒组降低(P<0.05)。结论 miR-106b可能通过下调RhoC的表达诱导鼻咽癌细胞凋亡并抑制鼻咽癌细胞增殖。
ABSTRACT: Objective To investigate the effect of miR-106b on the apoptosis and proliferation of nasopharyngeal carcinoma (NPC) cells. Methods We analyzed differences in miRNA expression in nasopharyngeal carcinoma and adjacent normal tissues with miRNA microarray. TaqMan miRNA detection kit and Real-time fluorescence quantitative PCR were used to detect the expressions of miR-106 and RhoC mRNA in nasopharyngeal carcinoma and adjacent tissues. The miR-106b and target gene binding sites were predicted with miRnada. The target gene was verified by double luciferase. Western blot was used to detect the expression of RhoC regulated by miR-106b. Annexin and TUNEL were used to detect the effect of miR-106b on the apoptosis of nasopharyngeal carcinoma cells; the effect of miR-106b on the proliferation of nasopharyngeal carcinoma cells was detected by MTT assay. Results miRNA microarray analysis showed that the expression of miR-106b was lower in NPC tissues than in adjacent normal tissues. The results of RT-PCR showed that the expression of miR-106b in nasopharyngeal carcinoma was decreased (P<0.05) while the expression of RhoC was increased in nasopharyngeal carcinoma (P<0.05). The expressions of miR-106b and RhoC in NPC were negatively correlated (r=-0.5866, P<0.001). The results of luciferase reporter assay showed that the activity of luciferase in miR-106b group was lower than that in empty plasmid group (P<0.05). The results of Western blot showed that miR-106b could decrease the expression of RhoC in NPC tissues (P<0.05). Annexin V-PI and TUNEL showed that the apoptosis of nasopharyngeal carcinoma cells was significantly higher in miR-106 group than in empty plasmid group (P<0.05). MTT results showed that the proliferation of nasopharyngeal carcinoma cells in miR-106b group was lower than that in empty plasmid group (P<0.05). Conclusion miR-106b may

References

[1]  SABA NF, SALAMA JK, BEITLER JJ, et al. ACR appropriateness criteria (R) for nasopharyngeal carcinoma[J]. Head Neck, 2016, 38(7):979-986.
[2]  ZHU K, HE Y, XIA C, et al. MicroRNA-15a inhibits proliferation and induces apoptosis in CNE1 nasopharyngeal carcinoma cells[J]. Oncol Res, 2016, 24(3):145-151.
[3]  WU A, WU K, LI J, et al. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma[J]. J Transl Med, 2015, 13:105.
[4]  SPENCE T, BRUCE J, YIP KW, et al. MicroRNAs in nasopharyngeal carcinoma[J]. Chin Clin Oncol, 2016, 5(2):17.
[5]  SANG XB, SUN KX, WANG LL, et al. Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis[J]. Oncol Rep, 2016. 7(34):55585-55600.
[6]  CHANG RM, PEI L, FANG F, et al. YMO1 suppresses invasion and metastasis by inhibiting RhoC signaling and predicts favorable prognosis in hepatocellular carcinoma[J]. Oncotarget, 2016, 7(34):55585.
[7]  ISLAM M, LIN G, BRENNER JC, et al. RhoC expression and head and neck cancer metastasis[J]. Mol Cancer Res, 2009, 7(11):1771-1780.
[8]  ISLAM M, SHARMA S, KUMAR B, et al. Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis[J]. Oral Oncol, 2013, 49(8):778-786.
[9]  LI XH, CHANG H, XU BQ, et al. An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: An analysis of a prospective study[J]. Cancer Med, 2016,22:4330-4337.
[10]  LEE KT, TAN JK, LAM AK, et al. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review[J]. Crit Rev Oncol Hematol, 2016, 103:1-9.
[11]  XU YF, MAO YP, LI YQ, et al. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2[J]. Cancer Lett, 2015, 363(2):146-155.
[12]  LI YQ, HE QM, REN XY, et al. MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma[J]. PLoS One, 2015, 10(3):e0122228.
[13]  CHEN X, SHI J, ZHONG J, et al. miR-1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma[J]. Int J Exp Pathol, 2015, 96(6):427-432.
[14]  HUANG S, LI X, ZHU H. MicroRNA-152 Targets phosphatase and tensin homolog to inhibit apoptosis and promote cell migration of nasopharyngeal carcinoma cells[J]. Med Sci Monit, 2016, 22:4330-4337.
[15]  LI Y, CHEN X. miR-4792 inhibits epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma by targeting FOXC1[J]. Biochem Biophys Res Commun, 2015, 468(4):863-869.
[16]  CARVALHEIRA G, NOZIMA BH, CERUTTI JM. microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer[J]. Oncotarget, 2015, 6(29):28357-28370.
[17]  DAI F, LIU T, ZHENG S, et al. MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh’s esophageal squamous cell carcinoma[J]. Tumour Biol, 2016, 37(11):14595-14604.
[18]  LI Y, CHEN D, SU Z, et al. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis[J]. Mol Med Rep, 2016, 13(2):1420-1426.
[19]  CHANG RM, PEI L, FANG F, et al. YMO1 suppresses invasion and metastasis by inhibiting RhoC signaling and predicts favorable prognosis in hepatocellular carcinoma[J]. Oncotarget, 2016, 7(34):55585-55600.
[20]  YANG H, LIANG J, ZHOU J, et al. Knockdown of RHOC by shRNA suppresses invasion and migration of cholangiocellular carcinoma cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal transition[J]. Mol Med Rep, 2016, 13(6):5255-5261.
[21]  CHEN X, CHEN S, XIU YL, et al. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression[J]. Mol Cancer, 2015, 14:31.
[22]  ZHAO Y, ZHENG HC, CHEN S, et al. The role of RhoC in ovarian epithelial carcinoma: A marker for carcinogenesis, progression, prognosis, and target therapy[J]. Gynecol Oncol, 2013, 130(3):570-578.
[23]  ZHOU W, ZHANG C, JIANG H, et al. MiR-493 suppresses the proliferation and invasion of gastric cancer cells by targeting RhoC[J]. Iran J Basic Med Sci, 2015, 18(10):1027-1033.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133